PHERGain was a randomized, non-comparative phase 2 trial evaluating a positron 18F-fluorodeoxyglucose-positron emission tomography (18F-FDG-PET)-guided, pathological complete response (pCR)-adapted strategy to omit chemotherapy in HER2-positive early breast cancer. Female patients with HER2-positive stages I-IIIA opera...
J. Pérez-García, J. Cortés, M. Ruíz-Borrego et al.· Nature Medicine· 0 citations
PURPOSE
Leptomeningeal disease (LMD) from breast cancer remains associated with poor outcomes and there are limited tools for quantitative response assessment. We evaluated cerebrospinal fluid (CSF) circulating tumour DNA (ctDNA) as a biomarker of treatment response in patients with LMD treated with trastuzumab deruxte...
A. Fitzpatrick, T. Shanmugalingam, S. Haider et al.· Clinical Cancer Research· 0 citations
BACKGROUND
Loneliness has been repeatedly linked to adolescents' exposure to online risks. However, the psychological mechanisms linking loneliness to online child sexual victimization remain insufficiently understood.
OBJECTIVE
The main aim was to examine the association between loneliness and online sexual victimiz...
Enrique Normand-Pascual, J. Pérez-García, Alberto Parrado-González et al.· International Journal of Chi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.